These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 8666909)

  • 1. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT; Payne JL; Goulet JL; Weller PF
    J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP; McColl SR; Braquet P; Borgeat P
    Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils.
    Bauldry SA; Wykle RL; Bass DA
    Biochim Biophys Acta; 1991 Jul; 1084(2):178-84. PubMed ID: 1854803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects.
    Bozza PT; Yu W; Cassara J; Weller PF
    J Leukoc Biol; 1998 Oct; 64(4):563-9. PubMed ID: 9766638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
    Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
    Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism.
    Pacheco P; Bozza FA; Gomes RN; Bozza M; Weller PF; Castro-Faria-Neto HC; Bozza PT
    J Immunol; 2002 Dec; 169(11):6498-506. PubMed ID: 12444160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation and priming of protein kinase C translocation by a Ca2+ transient-independent mechanism. Studies in human neutrophils challenged with platelet-activating factor and other receptor agonists.
    O'Flaherty JT; Redman JF; Jacobson DP; Rossi AG
    J Biol Chem; 1990 Dec; 265(35):21619-23. PubMed ID: 2174881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation.
    Bozza PT; Yu W; Penrose JF; Morgan ES; Dvorak AM; Weller PF
    J Exp Med; 1997 Sep; 186(6):909-20. PubMed ID: 9294145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and regulation of neutrophil priming by platelet-activating factor.
    Gay JC
    J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
    Qian C; Hwang SB; Libertine-Garahan L; Eckman JB; Cai X; Scannell RT; Yeh CG
    Pharmacol Res; 2001 Sep; 44(3):213-20. PubMed ID: 11529688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
    J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
    Glaser KB; Lock YW; Chang JY
    Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W; Javors MA; Olson MS
    Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction.
    Brady HR; Lamas S; Papayianni A; Takata S; Matsubara M; Marsden PA
    Am J Physiol; 1995 Jan; 268(1 Pt 2):F1-12. PubMed ID: 7840235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor stimulates intracellular calcium transients in human neutrophils: involvement of endogenous 5-lipoxygenase products.
    Rediske JJ; Quintavalla JC; Haston WO; Morrissey MM; Seligman B
    J Leukoc Biol; 1992 May; 51(5):484-9. PubMed ID: 1318349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.
    O'Flaherty JT; Nishihira J
    J Immunol; 1987 Mar; 138(6):1889-95. PubMed ID: 3029224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes.
    de Assis EF; Silva AR; Caiado LF; Marathe GK; Zimmerman GA; Prescott SM; McIntyre TM; Bozza PT; de Castro-Faria-Neto HC
    J Immunol; 2003 Aug; 171(4):2090-8. PubMed ID: 12902515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.